greeksoup/ stock research
Stock research / United States / ABBV / Documents

AbbVie Inc. documents

AbbVie (ABBV) annual report: the 10-K filed 20 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 23 March 2026; latest 10-Q filed 3 November 2026 for the quarter ended 30 September 2026. Each links to the document on EDGAR, with 8 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
30 October 2026Results press release, exhibit 99 to the 8-K filed 30 October 2026The releaseEDGAR folder
5 October 2026Results press release, exhibit 99 to the 8-K filed 5 October 2026The releaseEDGAR folder
31 July 2026Results press release, exhibit 99 to the 8-K filed 31 July 2026The releaseEDGAR folder
6 July 2026Results press release, exhibit 99 to the 8-K filed 6 July 2026The releaseEDGAR folder
29 April 2026Results press release, exhibit 99 to the 8-K filed 29 April 2026The releaseEDGAR folder
3 April 2026Results press release, exhibit 99 to the 8-K filed 3 April 2026The releaseEDGAR folder
4 February 2026Results press release, exhibit 99 to the 8-K filed 4 February 2026The releaseEDGAR folder
7 January 2026Results press release, exhibit 99 to the 8-K filed 7 January 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
20 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
3 November 202610-Q, period ended 30 September 2026The documentEDGAR folder
3 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
8 May 202610-Q, period ended 31 March 2026The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
23 March 2026DEF 14A, period ended 8 May 2026The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
23 March 2026ARS, period ended 31 December 2025The documentEDGAR folder

Employee plan reports

FiledDocumentOpenWhere
24 June 202611-K, period ended 31 December 2025The documentEDGAR folder